vs
Steris(STE)与Williams-Sonoma, Inc.(WSM)财务数据对比。点击上方公司名可切换其他公司
Williams-Sonoma, Inc.的季度营收约是Steris的1.3倍($1.9B vs $1.5B),Steris净利率更高(12.9% vs 12.8%,领先0.1%),Steris同比增速更快(9.2% vs 4.6%),Williams-Sonoma, Inc.自由现金流更多($248.1M vs $199.5M),过去两年Steris的营收复合增速更高(15.8% vs -9.1%)
Steris plc是一家美爱合资的医疗设备企业,专注于为美国医疗体系提供灭菌服务及外科手术相关产品。其实际运营总部位于美国俄亥俄州门托市,深耕医疗消毒、感染防控、手术耗材等领域,为医疗机构提供专业可靠的医疗解决方案。
Williams-Sonoma, Inc.是美国知名家居零售企业,1956年由查尔斯·E·威廉姆斯创立,主营高品质炊具、家居家电、家居软装等多元品类产品,在家居消费领域拥有广泛的用户基础与较高的市场认可度。
STE vs WSM — 直观对比
营收规模更大
WSM
是对方的1.3倍
$1.5B
营收增速更快
STE
高出4.6%
4.6%
净利率更高
STE
高出0.1%
12.8%
自由现金流更多
WSM
多$48.6M
$199.5M
两年增速更快
STE
近两年复合增速
-9.1%
损益表 — Q3 FY2026 vs Q3 FY2026
| 指标 | ||
|---|---|---|
| 营收 | $1.5B | $1.9B |
| 净利润 | $192.9M | $241.6M |
| 毛利率 | 43.8% | 46.1% |
| 营业利润率 | 18.3% | 17.0% |
| 净利率 | 12.9% | 12.8% |
| 营收同比 | 9.2% | 4.6% |
| 净利润同比 | 11.2% | -3.0% |
| 每股收益(稀释后) | $1.96 | $1.96 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
STE
WSM
| Q4 25 | $1.5B | $1.9B | ||
| Q3 25 | $1.5B | $1.8B | ||
| Q2 25 | $1.4B | $1.7B | ||
| Q1 25 | $1.5B | $2.5B | ||
| Q4 24 | $1.4B | $1.8B | ||
| Q3 24 | $1.3B | $1.8B | ||
| Q2 24 | $1.3B | $1.7B | ||
| Q1 24 | $1.1B | $2.3B |
净利润
STE
WSM
| Q4 25 | $192.9M | $241.6M | ||
| Q3 25 | $191.9M | $247.6M | ||
| Q2 25 | $177.4M | $231.3M | ||
| Q1 25 | $145.7M | $384.9M | ||
| Q4 24 | $173.5M | $249.0M | ||
| Q3 24 | $150.0M | $225.7M | ||
| Q2 24 | $145.4M | $265.7M | ||
| Q1 24 | $-1.4M | $354.4M |
毛利率
STE
WSM
| Q4 25 | 43.8% | 46.1% | ||
| Q3 25 | 44.2% | 47.1% | ||
| Q2 25 | 45.1% | 44.3% | ||
| Q1 25 | 43.3% | 45.2% | ||
| Q4 24 | 44.5% | 46.7% | ||
| Q3 24 | 43.6% | 46.2% | ||
| Q2 24 | 44.7% | 48.3% | ||
| Q1 24 | 40.2% | 46.0% |
营业利润率
STE
WSM
| Q4 25 | 18.3% | 17.0% | ||
| Q3 25 | 18.2% | 17.9% | ||
| Q2 25 | 17.7% | 16.8% | ||
| Q1 25 | 14.6% | 20.1% | ||
| Q4 24 | 17.9% | 17.8% | ||
| Q3 24 | 16.5% | 16.2% | ||
| Q2 24 | 14.5% | 19.5% | ||
| Q1 24 | 22.0% | 20.1% |
净利率
STE
WSM
| Q4 25 | 12.9% | 12.8% | ||
| Q3 25 | 13.1% | 13.5% | ||
| Q2 25 | 12.8% | 13.4% | ||
| Q1 25 | 9.8% | 15.6% | ||
| Q4 24 | 12.7% | 13.8% | ||
| Q3 24 | 11.3% | 12.6% | ||
| Q2 24 | 11.4% | 16.0% | ||
| Q1 24 | -0.1% | 15.6% |
每股收益(稀释后)
STE
WSM
| Q4 25 | $1.96 | $1.96 | ||
| Q3 25 | $1.94 | $2.00 | ||
| Q2 25 | $1.79 | $1.85 | ||
| Q1 25 | $1.48 | $1.02 | ||
| Q4 24 | $1.75 | $1.96 | ||
| Q3 24 | $1.51 | $1.74 | ||
| Q2 24 | $1.46 | $4.07 | ||
| Q1 24 | $-0.02 | $5.42 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $423.7M | $884.7M |
| 总债务越低越好 | $1.9B | — |
| 股东权益账面价值 | $7.2B | $2.1B |
| 总资产 | $10.6B | $5.3B |
| 负债/权益比越低杠杆越低 | 0.27× | — |
8季度趋势,按日历期对齐
现金及短期投资
STE
WSM
| Q4 25 | $423.7M | $884.7M | ||
| Q3 25 | $319.2M | $985.8M | ||
| Q2 25 | $279.7M | $1.0B | ||
| Q1 25 | $171.7M | $1.2B | ||
| Q4 24 | $155.2M | $826.8M | ||
| Q3 24 | $172.2M | $1.3B | ||
| Q2 24 | $198.3M | $1.3B | ||
| Q1 24 | $207.0M | $1.3B |
总债务
STE
WSM
| Q4 25 | $1.9B | — | ||
| Q3 25 | $1.9B | — | ||
| Q2 25 | $1.9B | — | ||
| Q1 25 | $1.9B | — | ||
| Q4 24 | $2.0B | — | ||
| Q3 24 | $2.2B | — | ||
| Q2 24 | $2.2B | — | ||
| Q1 24 | $3.1B | — |
股东权益
STE
WSM
| Q4 25 | $7.2B | $2.1B | ||
| Q3 25 | $7.0B | $2.1B | ||
| Q2 25 | $7.0B | $2.2B | ||
| Q1 25 | $6.6B | $2.1B | ||
| Q4 24 | $6.4B | $1.9B | ||
| Q3 24 | $6.6B | $2.3B | ||
| Q2 24 | $6.4B | $2.2B | ||
| Q1 24 | $6.3B | $2.1B |
总资产
STE
WSM
| Q4 25 | $10.6B | $5.3B | ||
| Q3 25 | $10.4B | $5.2B | ||
| Q2 25 | $10.4B | $5.2B | ||
| Q1 25 | $10.1B | $5.3B | ||
| Q4 24 | $10.0B | $5.0B | ||
| Q3 24 | $10.2B | $5.2B | ||
| Q2 24 | $10.1B | $5.2B | ||
| Q1 24 | $11.1B | $5.3B |
负债/权益比
STE
WSM
| Q4 25 | 0.27× | — | ||
| Q3 25 | 0.27× | — | ||
| Q2 25 | 0.27× | — | ||
| Q1 25 | 0.29× | — | ||
| Q4 24 | 0.32× | — | ||
| Q3 24 | 0.33× | — | ||
| Q2 24 | 0.35× | — | ||
| Q1 24 | 0.50× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $298.2M | $316.3M |
| 自由现金流经营现金流 - 资本支出 | $199.5M | $248.1M |
| 自由现金流率自由现金流/营收 | 13.3% | 13.2% |
| 资本支出强度资本支出/营收 | 6.6% | 3.6% |
| 现金转化率经营现金流/净利润 | 1.55× | 1.31× |
| 过去12个月自由现金流最近4个季度 | $917.1M | $1.1B |
8季度趋势,按日历期对齐
经营现金流
STE
WSM
| Q4 25 | $298.2M | $316.3M | ||
| Q3 25 | $287.8M | $282.7M | ||
| Q2 25 | $420.0M | $118.9M | ||
| Q1 25 | $260.8M | $633.5M | ||
| Q4 24 | $332.8M | $253.5M | ||
| Q3 24 | $250.7M | $246.5M | ||
| Q2 24 | $303.7M | $226.8M | ||
| Q1 24 | $254.8M | $674.9M |
自由现金流
STE
WSM
| Q4 25 | $199.5M | $248.1M | ||
| Q3 25 | $201.3M | $230.7M | ||
| Q2 25 | $326.4M | $60.7M | ||
| Q1 25 | $189.9M | $566.3M | ||
| Q4 24 | $243.6M | $170.1M | ||
| Q3 24 | $148.8M | $215.1M | ||
| Q2 24 | $195.7M | $187.3M | ||
| Q1 24 | $163.3M | $621.2M |
自由现金流率
STE
WSM
| Q4 25 | 13.3% | 13.2% | ||
| Q3 25 | 13.8% | 12.6% | ||
| Q2 25 | 23.5% | 3.5% | ||
| Q1 25 | 12.8% | 23.0% | ||
| Q4 24 | 17.8% | 9.4% | ||
| Q3 24 | 11.2% | 12.0% | ||
| Q2 24 | 15.3% | 11.3% | ||
| Q1 24 | 14.6% | 27.3% |
资本支出强度
STE
WSM
| Q4 25 | 6.6% | 3.6% | ||
| Q3 25 | 5.9% | 2.8% | ||
| Q2 25 | 6.7% | 3.4% | ||
| Q1 25 | 4.8% | 2.7% | ||
| Q4 24 | 6.5% | 4.6% | ||
| Q3 24 | 7.7% | 1.8% | ||
| Q2 24 | 8.4% | 2.4% | ||
| Q1 24 | 8.2% | 2.4% |
现金转化率
STE
WSM
| Q4 25 | 1.55× | 1.31× | ||
| Q3 25 | 1.50× | 1.14× | ||
| Q2 25 | 2.37× | 0.51× | ||
| Q1 25 | 1.79× | 1.65× | ||
| Q4 24 | 1.92× | 1.02× | ||
| Q3 24 | 1.67× | 1.09× | ||
| Q2 24 | 2.09× | 0.85× | ||
| Q1 24 | — | 1.90× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
STE
| Servicerevenues | $404.7M | 27% |
| Consumablerevenues | $387.1M | 26% |
| Applied Sterilization Technologies | $286.6M | 19% |
| Capitalequipmentrevenues | $272.1M | 18% |
| Life Science | $145.8M | 10% |
WSM
暂无分部数据